Revolution in medicine: Bionanoparticles bring hope for cancer!

Revolution in medicine: Bionanoparticles bring hope for cancer!

Laimgrubengasse 10, 1060 Wien, Österreich - The biopharmaceutical industry is experiencing an exciting turn with the development of bionanoparticles, a new class of molecules that could revolutionize medicine. The Doctoral Network Caare, coordinated by the Austrian Center of Industrial Biotechnology (ACIB), receives generous funding of EUR 3.6 million from EU funds. This innovative project combines 16 European partners and trains 14 doctoral students who specialize in the processing of these modern particles.

bionanoparticles are essential supports of current biopharmaceuticals, including conventional and mRNA vaccines as well as genetic therapies. These technologies could play a crucial role in the treatment of diseases that were previously considered to be incurable as cancer and in supporting patients with rare diseases. The focus of the Caare network is on improving the cleaning processes and the characterization of these particles during production to ensure the quality of the therapies. Current analysis methods are often inadequate to identify emptiness or only partially filled particles exactly, which could affect the effectiveness of the treatments, such as ots.at reported.

research at the highest level

At the same time, the graduate center of TH Cologne promotes the scientific qualification of doctoral students and postdocs. Various doctoral structures are supported, including individual and structured programs. The central facility not only promotes young scientists, but also offers extensive advice and support offers for everyone who is in the early career phase. The aim is to secure the quality of scientific work and to open up new career paths, so th-koeln.de .

With these initiatives, not only is biopharmaceutical research promoted, but a new generation of scientists is also trained, which are helped to shape the medical landscape of the future.